Neurocrine Biosciences Reports First-Quarter 2026 Financial Results
Go back to Neurocrine Biosciences Reports First-Quarter 2026 Financial Results| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 156.22 -0.35 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.57 | 52 Week High | $58.46 | |||
| Open | $157.20 | 52 Week Low | $31.25 | |||
| Day High | $159.67 | P/E | N/A | |||
| Day Low | $156.12 | EPS | $-0.69 | |||
| Volume | 890,874 | |||||

